Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
iPremom raises €15 million in Seed funding to advance the early detection of pregnancy complications through its MaiRa platform, led by Amadeus Capital Partners.
Apex VenturesAsabys PartnersAmadeus Capital Partners
Description
iPremom, a Spanish molecular diagnostics company, has raised €15 million in Seed funding to support the clinical validation and commercial rollout of its MaiRa platform. This platform analyzes early signals of first-trimester pregnancy complications through blood tests. The round was led by Amadeus Capital Partners, with participation from Asabys Partners and APEX Ventures. The funding marks a critical step toward making comprehensive early molecular assessments available for pregnant women.
Company Information
Company
iPremom
Location
Valencia, Valencian Community, Spain
About
iPremom is a Spanish molecular diagnostics company founded in 2019 that focuses on the early prediction and prevention of pregnancy complications through advanced molecular diagnostics and AI-based predictive models. Its MaiRa platform analyzes early signals of first-trimester pregnancy complications via blood tests. The company aims to provide comprehensive, early molecular insights to improve prenatal care. iPremom seeks to transform the landscape of prenatal diagnostics by identifying risks well before clinical symptoms manifest.
Don't miss iPremom's next move
Get an email the moment iPremom raises, hires an exec, or expands, usually minutes after it happens.
ValenciaBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics